220 related articles for article (PubMed ID: 17022079)
1. Attitudes and beliefs of pediatricians and genetic counselors regarding testing and screening for CF and G6PD: implications for policy.
Koopmans J; Hiraki S; Ross LF
Am J Med Genet A; 2006 Nov; 140(21):2305-11. PubMed ID: 17022079
[TBL] [Abstract][Full Text] [Related]
2. Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children.
Hiraki S; Ormond KE; Kim K; Ross LF
Am J Med Genet A; 2006 Nov; 140(21):2312-9. PubMed ID: 17036312
[TBL] [Abstract][Full Text] [Related]
3. Does familiarity breed acceptance? The influence of policy on physicians' attitudes toward newborn screening programs.
Koopmans J; Ross LF
Pediatrics; 2006 May; 117(5):1477-85. PubMed ID: 16651300
[TBL] [Abstract][Full Text] [Related]
4. Pediatricians' attitudes toward expanding newborn screening.
Acharya K; Ackerman PD; Ross LF
Pediatrics; 2005 Oct; 116(4):e476-84. PubMed ID: 16199673
[TBL] [Abstract][Full Text] [Related]
5. A pilot study to evaluate knowledge and attitudes of Illinois pediatricians toward newborn screening for sickle cell disease and cystic fibrosis.
Stark AP; Lang CW; Ross LF
Am J Perinatol; 2011 Mar; 28(3):169-76. PubMed ID: 20830657
[TBL] [Abstract][Full Text] [Related]
6. Genetic Counselors' Experience with and Opinions on the Management of Newborn Screening Incidental Carrier Findings.
Leppert K; Bisordi K; Nieto J; Maloney K; Guan Y; Dixon S; Egense A
J Genet Couns; 2018 Dec; 27(6):1328-1340. PubMed ID: 29687313
[TBL] [Abstract][Full Text] [Related]
7. Pediatricians' attitudes about screening newborns for infectious diseases.
Schittek H; Koopmans J; Ross LF
Matern Child Health J; 2010 Mar; 14(2):174-83. PubMed ID: 19067138
[TBL] [Abstract][Full Text] [Related]
8. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM
Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747
[TBL] [Abstract][Full Text] [Related]
9. Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors.
Langfelder-Schwind E; Karczeski B; Strecker MN; Redman J; Sugarman EA; Zaleski C; Brown T; Keiles S; Powers A; Ghate S; Darrah R
J Genet Couns; 2014 Feb; 23(1):5-15. PubMed ID: 24014130
[TBL] [Abstract][Full Text] [Related]
10. Understanding newborn screening system issues with emphasis on cystic fibrosis screening.
Therrell BL; Lloyd-Puryear MA; Mann MY
J Pediatr; 2005 Sep; 147(3 Suppl):S6-10. PubMed ID: 16202785
[TBL] [Abstract][Full Text] [Related]
11. Newborn screening: education, consent, and the residual blood spot. The position of the national society of genetic counselors.
Blout C; Walsh Vockley C; Gaviglio A; Fox M; Croke B; Williamson Dean L;
J Genet Couns; 2014 Feb; 23(1):16-9. PubMed ID: 23881473
[TBL] [Abstract][Full Text] [Related]
12. Preconceptional cystic fibrosis carrier screening: opinions of general practitioners, gynecologists, and pediatricians in the Netherlands.
Baars MJ; Henneman L; ten Kate LP
Genet Test; 2004; 8(4):431-6. PubMed ID: 15684876
[TBL] [Abstract][Full Text] [Related]
13. Practice variation of genetic counselor engagement in the cystic fibrosis newborn screen-positive diagnostic resolution process.
Langfelder-Schwind E; Raraigh KS; Parad RB
J Genet Couns; 2019 Dec; 28(6):1178-1188. PubMed ID: 31550062
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Provider Insight Into Newborn Screening for Glucose-6-Phosphate Dehydrogenase Deficiency.
Bernardo J; Nock M
Clin Pediatr (Phila); 2015 Jun; 54(6):575-8. PubMed ID: 25385930
[TBL] [Abstract][Full Text] [Related]
15. Challenges in implementing a successful newborn cystic fibrosis screening program.
Comeau AM; Parad R; Gerstle R; O'Sullivan BP; Dorkin HL; Dovey M; Haver K; Martin T; Eaton RB
J Pediatr; 2005 Sep; 147(3 Suppl):S89-93. PubMed ID: 16202791
[TBL] [Abstract][Full Text] [Related]
16. Pediatric and Adult Recommendations Vary for Sibling Testing in Cystic Fibrosis.
Brown KL; Flume PA
J Genet Couns; 2018 Sep; 27(5):1049-1054. PubMed ID: 29429040
[TBL] [Abstract][Full Text] [Related]
17. Communications systems and their models: Massachusetts parent compliance with recommended specialty care after positive cystic fibrosis newborn screening result.
Comeau AM; Parad R; Gerstle R; O'Sullivan BP; Dorkin HL; Dovey M; Haver K; Martin T; Eaton RB
J Pediatr; 2005 Sep; 147(3 Suppl):S98-100. PubMed ID: 16202793
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the National Society of Genetic Counselors.
Langfelder-Schwind E; Kloza E; Sugarman E; Pettersen B; Brown T; Jensen K; Marcus S; Redman J;
J Genet Couns; 2005 Feb; 14(1):1-15. PubMed ID: 15789152
[TBL] [Abstract][Full Text] [Related]
19. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the effects of disclosing carrier results generated through newborn screening.
Hayeems RZ; Bytautas JP; Miller FA
J Genet Couns; 2008 Dec; 17(6):538-49. PubMed ID: 18956236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
